A detailed history of American Portfolios Advisors transactions in Outset Medical, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 50 shares of OM stock, worth $60. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Holding current value
$60
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$14.67 - $21.7 $733 - $1,085
50 New
50 $797,000
Q4 2021

Mar 21, 2023

BUY
$43.29 - $58.77 $34,632 - $47,016
800 Added 1600.0%
850 $39.2 Million
Q3 2021

Mar 22, 2023

BUY
$36.86 - $54.98 $29,488 - $43,984
800 Added 1600.0%
850 $42 Million
Q2 2021

Mar 22, 2023

BUY
$41.49 - $59.92 $33,192 - $47,936
800 Added 1600.0%
850 $42.5 Million
Q1 2021

Mar 22, 2023

BUY
$46.94 - $58.66 $35,205 - $43,995
750 Added 1500.0%
800 $43.5 Million
Q4 2020

Mar 22, 2023

BUY
$42.51 - $64.0 $31,882 - $48,000
750 Added 1500.0%
800 $45.5 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $58.1M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.